Publications
473
Citations
18,409
Est. group size
~1
Recurring co-author estimate
Active years
37
Publishing since 1990
Typically publishes in teams of ~8 · 27% small-team papers (≤3 authors) · across 127 venues
- Induction of human pruriceptors from pluripotent stem cells via transcription factors
Stem Cell Reports · 2026
- Chronic Urticaria Part II: Clinical management and therapeutics
Journal of the American Academy of Dermatology · 2026
- IL-13 signaling in cDC2 is required for systemic anaphylactic responses
Proceedings of the National Academy of Sciences · 2026
- Efficacy of Lebrikizumab on Pruritus: A Narrative Review
Advances in Therapy · 2025
- Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria
Dermatology and Therapy · 2025
- The Primate Hippocampus Constructs a Temporal Scaffold Anchored to Behavioral Events
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Impact of Amlitelimab (An Anti-OX40 Ligand Antibody) on Maintenance of Itch Response in Atopic Dermatitis: Results From the 52-Week STREAM-AD Phase 2b Study
SKIN The Journal of Cutaneous Medicine · 2025
- 48 Basophil–Pro-inflammatory Fibroblast Loop Mediates Type 2 Skin Inflammation
Journal of Investigative Dermatology · 2025
- 148 KLK7 as a key mediator of dry skin itch
Journal of Investigative Dermatology · 2025
- Quantitative metatranscriptomics and biogeochemical rate measurements reveal microbial pathways driving carbon and nitrogen cycles in an Arctic coastal lagoon
Limnology and Oceanography · 2025
- SUN-784 Intersecting Malignant And Endocrine Drivers Of Hypercalcemia: A Case-based Analysis
Journal of the Endocrine Society · 2025
- The Aircraft nvPM Mission Emissions Estimation Methodology, Version 2 (MEEM2)
SAE technical papers on CD-ROM/SAE technical paper series · 2025
- Optimal Itch Response in Adults Treated with Dupilumab for Moderate-to-Severe Atopic Dermatitis
Dermatology and Therapy · 2025
- 63337 Real-World Prevalence of Comorbidities Among Adult Patients With Prurigo Nodularis With and Without Type 2 Inflammatory Diseases in the US
Journal of the American Academy of Dermatology · 2025
- 62198 Impact of amlitelimab (an anti-OX40 Ligand antibody) on maintenance of itch response in atopic dermatitis: results from the 52-week STREAM-AD Phase 2b study
Journal of the American Academy of Dermatology · 2025
- Journal of Allergy and Clinical Immunology×24
- Journal of the American Academy of Dermatology×24
- Journal of Investigative Dermatology×15
- British Journal of Dermatology×14
- The American Journal of Gastroenterology×11
- Brian T. Cheng
Medicine · Indiana University
- Stephanie S. Lee
Medicine · University of Michigan
- Hongming Zhou
Medicine · Indiana University
- Seitaro Nakagawa
Medicine · University of Michigan
- Ranjitha Uppala
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile